Therefore, this study aimed to explore the clinical significance of serum cystatin C and lipid profile abnormalities for the differential diagnosis of diabetic nephropathy and non-diabetic nephropathy in patients with T2DM. This evidence concerns the gene CST3 and type 2 diabetes mellitus.